Firefly Neuroscience jumps on U.S. military health partnership

Shares of medtech firm Firefly Neuroscience AIFF.O rise 24.99% to $2.10 premarket

Co says it has entered a partnership with the U.S. Department of War, tied to U.S. military health programs

Says its FDA-cleared brain scan technology will be used to help assess and treat post-traumatic stress disorder and traumatic brain injury in active-duty service members and veterans

Says the technology gives healthcare providers brain data to help with diagnosis, treatment planning and tracking patient progress

Adds the partnership expands its commercial reach into the U.S. government and defense health sectors

Specific details of the partnership and related programs remain confidential - AIFF

AIFF shares were down over 66% in 2025